Steroid-resistant asthma. Cellular mechanisms contributing to inadequate response to glucocorticoid therapy.
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
The current study examined whether alterations in glucocorticoid receptor (GR) binding contribute to poor response to glucocorticoid therapy in asthma. 29 asthma patients with forced expiratory volume in 1 s (FEV1) < 70% predicted were studied. Patients were classified as steroid sensitive (SS) if their morning FEV1 increased > 30% after a 1-wk course of oral prednisone 20 mg twice daily and steroid resistant (SR) if they failed to increase > 15%. PBMC obtained from these two groups, 17 SR and 12 SS, as well as 12 normal controls were analyzed. SR patients had two distinguishable GR binding abnormalities: 15 of the 17 SR patients demonstrated a significantly reduced GR binding affinity, as compared with SS patients (P = 0.0001) and normal controls (P = 0.0001). This defect was localized to T cells and reverted to normal after 48 h in culture media. However, incubation with a combination of IL-2 and IL-4 sustained this abnormality. The other two SR patients had an abnormally low GR number with normal binding affinity that was not limited to T cells. Furthermore, GR number failed to normalize after incubation in media alone or IL-2 and IL-4. Therefore, SR asthma may be due to more than one abnormality, the majority related to a reversible cytokine-induced reduction in GR binding affinity and the second related to an irreversible reduction in GR number. These findings may have important implications for the design of alternative treatment approaches for recalcitrant asthma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Predominant TH2-like Bronchoalveolar T-Lymphocyte Population in Atopic Asthma
Robinson, D. S., Hamid, Q., Ying, S., Tsicopoulos, A., Barkans, J., Bentley, A. M., Corrigan, C., Durham, S. R., & Kay, A. B. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201303260504 · Cited by 2,768
Yang-Yen, H.-F., Chambard, J.-C., Sun, Y.-L., Smeal, T., Schmidt, T. J., Drouin, J., & Karin, M. (1990) · Cell · doi:10.1016/0092-8674(90)90396-v · Cited by 1,553
Diamond, M. I., Miner, J. N., Yoshinaga, S. K., & Yamamoto, K. R. (1990) · Science · doi:10.1126/science.2119054 · Cited by 1,292
Walker, C., Bode, E., Boer, L., Hansel, T. T., Blaser, K., & Virchow, J.-C. (1992) · American Review of Respiratory Disease · doi:10.1164/ajrccm/146.1.109 · Cited by 768
Nuclear factor of activated T cells contains Fos and Jun
Jain, J., McCaffrey, P. G., Valge-Archer, V. E., & Rao, A. (1992) · Nature · doi:10.1038/356801a0 · Cited by 498
Biochemistry, Molecular Biology, and Physiology of the Glucocorticoid Receptor*
GUSTAFSSON, J.-Å., CARLSTEDT-DUKE, J., POELLINGER, L., OKRET, S., WIKSTRÖM, A.-C., BRÖNNEGÅRD, M., GILLNER, M., DONG, Y., FUXE, K., CINTRA, A., et al. (1987) · Endocrine Reviews · doi:10.1210/edrv-8-2-185 · Cited by 403
Hurley, D. M., Accili, D., Stratakis, C. A., Karl, M., Vamvakopoulos, N., Rorer, E., Constantine, K., Taylor, S. I., & Chrousos, G. P. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115046 · Cited by 370
Corrigan, C. J., Brown, P. H., Barnes, N. C., Szefler, S. J., Tsai, J.-J., Frew, A. J., & Kay, A. B. (1991) · American Review of Respiratory Disease · doi:10.1164/ajrccm/144.5.1016 · Cited by 251
Self-citationPrimary cortisol resistance in man. A glucocorticoid receptor-mediated disease.
Chrousos, G. P., Vingerhoeds, A., Brandon, D., Eil, C., Pugeat, M., DeVroede, M., Loriaux, D. L., & Lipsett, M. B. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110565 · Cited by 250
Corticosteroid resistance in chronic asthma.
Carmichael, J., Paterson, I. C., Diaz, P., Crompton, G. K., Kay, A. B., & Grant, I. W. (1981) · BMJ · doi:10.1136/bmj.282.6274.1419 · Cited by 234
Corrigan, C. J., Brown, P. H., Barnes, N. C., Tsai, J.-J., Frew, A. J., & Kay, A. B. (1991) · American Review of Respiratory Disease · doi:10.1164/ajrccm/144.5.page · Cited by 173
NOCTURNAL ADRENAL SUPPRESSION IN ASTHMATIC CHILDREN TAKING INHALED BECLOMETHASONE DIPROPIONATE
Law, C., Honour, J. W., Marchant, J. L., Preece, M. A., & Warner, J. O. (1986) · The Lancet · doi:10.1016/s0140-6736(86)91045-7 · Cited by 158
Steroid Resistance in Bronchial Asthma
Schwartz, H. J., Lowell, F. C., & Melby, J. C. (1968) · Annals of Internal Medicine · doi:10.7326/0003-4819-69-3-493 · Cited by 156
Glucocorticoid receptors and actions.
Munck, A. U., Mendel, D. B., Smith, L. I., & Ortí, E. (1990) · PubMed · Cited by 133
Glucocorticoid therapy for asthma: Clinical pharmacology
Szefler, S. J. (1991) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(91)90323-g · Cited by 109
Self-citationSteroid-resistant asthma: Immunologic and pharmacologic features
Alvarez, J., Surs, W., LEUNG, D., Iklé, D. N., Gelfand, E. W., & Szefler, S. J. (1992) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(92)90379-g · Cited by 106
Self-citationMonitoring glucocorticoid therapy: a pharmacokinetic approach
Hill, M. R., Szefler, S. J., Ball, B. D., Bartoszek, M., & Brenner, A. M. (1990) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1990.167 · Cited by 103
Tabachnik, E., & Zadik, Z. (1991) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)80506-2 · Cited by 71
Endogenous cortisol regulates immunoglobulin E-dependent late phase reactions.
Herrscher, R. F., Kasper, C., & Sullivan, T. J. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115898 · Cited by 71
Anti-inflammatory drugs in the treatment of allergic disease
Szefler, S. J. (1992) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)30334-0 · Cited by 19
Self-citationSteroid resistance in asthma: Our current understanding
Kamada, A. K., Leung, D. Y. M., & Szefler, S. J. (1992) · Pediatric Pulmonology · doi:10.1002/ppul.1950140307 · Cited by 18
Self-citation
Cited by
The Hypothalamic–Pituitary–Adrenal Axis and Immune-Mediated Inflammation
Chrousos, G. P. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505183322008 · Cited by 2,579
Salivary cortisol as a biomarker in stress research
Hellhammer, D. H., Wüst, S., & Kudielka, B. M. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.10.026 · Cited by 1,925
The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders
Heim, C., Ehlert, U., & Hellhammer, D. H. (2000) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(99)00035-9 · Cited by 1,688
“Decreased GR number or affinity has also been observed in disorders with a more obvious pathophyisological basis, such as rheumatoid arthritis and asthma (Schlaghecke et al., 1992; Sher et al., 1994; Spahn et al., 1995).”
BackgroundGlucocorticoid receptors in major depression: relevance to pathophysiology and treatment
Pariante, C. M., & Miller, A. H. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01088-x · Cited by 1,147
Glucocorticoid resistance in inflammatory diseases
Barnes, P. J., & Adcock, I. M. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60326-3 · Cited by 983
Metadata
- Authors
- Sher, E. R., Leung, D. Y., Surs, W., Kam, J. C., Zieg, G., Kamada, A. K., & Szefler, S. J.
- Venue
- Journal of Clinical Investigation
- Published
- 1994-01-01
- Volume
- 93
- Issue
- 1
- Pages
- 33-39
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W1969304196
- Cited by
- 393
- References
- 21
- FWCI
- 15.80
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.